Voxel-Based Analysis for Identification of Urethrovesical Subregions Predicting Urinary Toxicity After Prostate Cancer Radiation Therapy.
Aged
Aged, 80 and over
Computer Graphics
Dysuria
/ diagnostic imaging
Hematuria
/ diagnostic imaging
Humans
Male
Middle Aged
Prospective Studies
Prostatic Neoplasms
/ radiotherapy
Radiation Injuries
/ diagnostic imaging
Radiotherapy, Image-Guided
/ adverse effects
Radiotherapy, Intensity-Modulated
/ adverse effects
Regression Analysis
Urethra
/ diagnostic imaging
Urinary Bladder
/ diagnostic imaging
Urinary Incontinence
/ diagnostic imaging
Urinary Retention
/ diagnostic imaging
Journal
International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616
Informations de publication
Date de publication:
01 06 2019
01 06 2019
Historique:
received:
11
08
2018
revised:
22
01
2019
accepted:
26
01
2019
pubmed:
5
2
2019
medline:
15
11
2019
entrez:
5
2
2019
Statut:
ppublish
Résumé
To apply a voxel-based analysis to identify urethrovesical symptom-related subregions (SRSs) associated with acute and late urinary toxicity in prostate cancer radiation therapy. Two hundred seventy-two patients with prostate cancer treated with intensity-modulated radiation therapy/image-guided radiation therapy were analyzed prospectively. Each patient's computed tomography imaging was spatially normalized to a common coordinate system via nonrigid registration. The obtained deformation fields were used to map the dose of each patient to the common coordinate system. A voxel-based statistical analysis was applied to generate 3-dimensional dose-volume maps for different urinary symptoms, allowing the identification of corresponding SRSs with statistically significant dose differences between patients with or without toxicity. Each SRS was propagated back to each individual's native space, and dose-volume histograms (DVHs) for the SRSs and the whole bladder were computed. Logistic and Cox regression were used to estimate the SRS's prediction capability compared with the whole bladder. A local dose-effect relationship was found in the bladder and the urethra. SRSs were identified for 5 symptoms: acute incontinence in the urethra, acute retention in the bladder trigone, late retention and dysuria in the posterior part of the bladder, and late hematuria in the superior part of the bladder, with significant dose differences between patients with and without toxicity, ranging from 1.2 to 9.3 Gy. The doses to the SRSs were significantly predictive of toxicity, with maximum areas under the receiver operating characteristic curve of 0.73 for acute incontinence, 0.62 for acute retention, 0.70 for late retention, 0.81 for late dysuria, and 0.67 for late hematuria. The bladder DVH was predictive only for late retention, dysuria, and hematuria (area under the curve, 0.65-0.72). The dose delivered to the urethra and the posterior and superior parts of the bladder was predictive of acute incontinence and retention and of late retention, dysuria, and hematuria. The dose to the whole bladder was moderately predictive.
Identifiants
pubmed: 30716523
pii: S0360-3016(19)30179-8
doi: 10.1016/j.ijrobp.2019.01.088
pii:
doi:
Types de publication
Clinical Trial, Phase III
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
343-354Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.